Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INTERVIEW: KDDF CEO On Building R&D Success, Pipelines

This article was originally published in PharmAsia News

Executive Summary

The South Korean pharma industry and government are notching up efforts to pursue open innovation for successful R&D, and the state-run Korea Drug Development Fund (KDDF) is at the center of this push. The CEO of the fund, which is supported by multiple government ministries, talks to PharmAsia News about how it is supporting domestic firms to more successfully acquire and develop novel global drugs.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC089322

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel